Dry nasal spray receives FDA stamp of approval
During allergy season, those sensitive to irritants will try anything in their treatment arsenals to combat symptoms. Following FDA approval, consumers now have access to a dry form of nasal sprays.
One of the more common forms of treatment allergy sufferers use during spring months are nasal sprays. These treatments are available with a prescription or over-the-counter, depending on a patient's particular needs.
Many nasal sprays are designed specifically to target inflammation in the nose, which is what causes congestion. They are generally effective because medication is applied directly to the nasal cavity.
The downside to these sprays is that many users find the lingering moisture in their nose to be very uncomfortable. Some may avoid these medications altogether or use them so sparingly that they are not truly effective.
"With the corticosteroid nasal sprays, it's important for patients to use them consistently," Dr. Gary Gross, co-founder of the Dallas Allergy and Asthma Center, told WebMD. "But, some people don't like the drip down the back of the nose, the feeling of moisture. They are reluctant to use currently available sprays."
In response to this problem, patients now have access to Qnasl, a powder nasal spray recently approved for use by the FDA. Qnasl is a corticosteroid that combats nasal congestion and sneezing without the uncomfortable side effects of liquid sprays.
Excessive use of nasal sprays, whether in liquid or powder forms, can cause the nose to become less responsive to such treatments, so patients should avoid taking sprays more than five days consecutively, with only a few treatments being used each day. Constant congestion might cause a patient to consider exceeding the suggested dosages, but this is not recommended by medical professionals.